Abstract
Primary hyperoxaluria type 1 (PH1) is a rare recessive autosomal inborn error of glyoxylate metabolism leading to oxalate retention, the first target of which is the kidney. The disease is caused by a defect of the liver-specific peroxisomal enzyme alanine: glyoxylate aminotransferase. Patients with pyridoxine-resistant forms of PH1 usually require organ replacement therapy, i.e. liver transplantation to supply the deficient enzyme and/or kidney transplantation to replace the affected organ. The current experience of the management of Ph1 has emphasized two main points: (1) end-stage renal failure must be avoided since it increases dramatically the risk of systemic involvement, (2) the correction of oxalate overproduction and organ overload requires the removal of the host liver. Practical attitudes towards these ideas are difficult to assess and an individualized strategy is therefore required. Isolated kidney transplantation should be limited to adult patients with late-onset and a mild course of the disease. The present experience of combined liver-kidney transplantation was gained mainly in adult patients with severe systemic involvement; the 3-year patient survival rate recently increased to 82%. This figure might be improved if the procedure were performed earlier while the glomerular filtration rate (GFR) is above 25 ml/min per 1.73 m2. Isolated liver transplantation should be considered in carefully selected children with severe forms of pyridoxineresistance (PH1) before GFR has dropped to less than 30 ml/min per 1.73 m2; it seems to be indicated especially in the presence of a rapid decline of GFR in the preceding year. In two young children who underwent isolated liver transplantation in our units 4 years ago, renal function could be stabilized and severe extrarenal involvement prevented.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Danpure CJ (1991) Molecular and clinical heterogeneity in primary hyperoxaluria type 1. Am J Kidney Dis 17:366–369
Danpure CJ, Jennings PR (1986) Peroxisomal alanine: glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 201:20–24
Danpure CJ (1991) Scientific rationale for hepato-renal transplantation in primary hyperoxaluria type 1. Transplant Clin Immunol 22:91–98
Latta K, Brodehl J (1990) Primary hyperoxaluria type I. Eur J Pediatr 149:518–522
Watts RWE, Mansell MA (1990) Oxalate, livers, and kidneys. Combined renal and hepatic transplants transform the outlook in primary hyperoxaluria type I. B M J 301:772–773
Scheinman JI, Najarian JS, Mauer SM (1984) Successful strategies for renal transplantation in primary oxalosis. Kidney Int 25:804–811
Leumann EP, Niederwieser A, Fanconi A (1987) New aspects of infantile oxalosis. Pediatr Nephrol 1:531–535
Morgan SH, Purkiss P, Watts RWE, Mansell MA (1987) Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria. Nephron 46:253–257
Watts RWE, Danpure CJ, De Pauw L, Toussaint C and the European Study Group on Transplantation in Hyperoxaluria Type 1 (1991) Combined liver-kidney and isolated liver-transplantation for primary hyperoxaluria type 1: the European experience. Nephrol Dial Transplant 6:502–511
Lloveras JJ, Dupré-Goudable C, Rey JP, Sporer P, Durand D, Ton That H, Suc JM (1991) Experience européenne de transplantation hépato-rénale dans l'hyperoxalurie primitive de type 1. Prévention de la récidive des dépots d'oxalate au niveau du rein. Presse Med 20:2016–2018
Deodhar SD, Tung KSK, Zühlke V, Nakamoto S (1969) Renal homotransplantation in a patient with primary familial oxalosis. Arch Pathol 87:118–124
Watts RWE, Calne RY, Rolles K, Danpure CJ, Morgan SH, Mansell MA, Williams R, Purkiss P (1987) Successful treatment of primary hyperoxaluria type 1 by combined hepatic and renal transplantation. Lancet II:474–475
Watts RWE, Morgan SH, Purkiss P, Mansell MA, Baker LRI, Brown CB (1988) Timing of renal transplantation in the management of pyridoxine-resistant type 1 primary hyperoxaluria. Transplantation 45:1143–1145
Katz A, Mauer SM (1992) Transplantation in primary hyperoxaluria type 1. Am J Med 92:341–342
Broyer M, Brunner FP, Brynger H, Dykes SR, Ehrich HH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufveson G, Wing AJ (1990). Kidney transplantation in primary oxalosis: data from the EDTA registry. Nephrol Dial Transplant 5:332–336
Watts RWE, Morgan SH, Danpure CJ, Purkiss P, Calne RY, Rolles K, Baker LRI, Mansell MA, Smith LH, Merion RM, Lucey MR (1991) Combined hepatic and renal transplantation in primary hyperoxaluria type 1: clinical report of 9 cases. Am J Med 90:179–188
Katz A, Kim Y, Scheinman JI, Najarian JS, Mauer SM (1989) Long-term outcome of kidney transplantation in children with oxalosis. Transplant Proc 21:2033–2035
Friedmann T (1991) Approaches to human gene therapy. In: Schaub J, Van Hoof F, Vis HL (eds) Inborn errors of metabolism. Nestlé Nutrition Workshop Series, vol. 24. Raven, New York, pp 275–282
Cochat P, Guibaud P (1991) Principles of organ transplantation in inborn errors of metabolism. Transplant Clin Immunol 22:73–82
Malatack JJ, Finegold DN, Iwatsuki S, Shaw BW, Gartner JC, Zitelli BJ, Roe T, Starzl TE (1983) Liver transplantation for type 1 glycogen storage diseases. Lancet I:1073–1075
Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS (1984) Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 311:1658–1664
Terpstra OT, Reuvers CB, Schlam SW (1989) Auxiliary heterotopic liver transplantation. Transplantation 45:1003–1007
Gordon RD, Todo S, Tzakis AG, Fung JJ, Stieber A, Staschak SM, Iwatsuki S, Starzl TE (1991) Liver transplantation under cyclosporine: a decade of experience. Transplant Proc 23:1393–1396
Cohen AT, Mowat AP, Bhaduri BH, Noble-Jamieson G, Williams R. Barnes, Calne RY (1991) Liver transplantation for inborn errors of metabolism and genetic disorders. In: Schaub J, Van Hoof F, Vis HL (eds) Inborn errors of metabolism; Nestlé Nutrition Workshop Series, vol. 24. Raven, New York, pp 213–222
Bismuth H, Castaing D, Ericzon BG, Otte JB, Ringer B, Rolles K, Sloff MJH (1991) European liver transplant registry: updating 30.06.91. Sandoz (ed), Paris
Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Klintmalm GB (1991) Long term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome. Experience in 300 patients. Transplantation 51:428–430
Watts RWE, Calne RY, Williams R, Mansell MA, Veall N, Purkiss P, Rolles K (1985) Primary hyperoxaluria (type 1): attempted treatment by combined hepatic and renal transplantation. Q J Med 57:697–703
Jamieson NV, Watts RWE, Evans DB, Williams R, Calne RY (1991) Liver and kidney transplantation in the treatment of primary hyperoxaluria. Transplant Proc 23:1557–1558
Polinski MS, Dunn S, Kaiser BA, Schulman SL, Wolfson BJ, Elfenhein IB, Baluarte HJ (1991) Combined liver-kidney transplantation in a child with primary hyperoxaluria. Pediatr Nephrol 5:332–334
Jouvet P, Hubert P, Jan D, Niaudet P, Beringer A, Narcy C, Daudon M, Broyer M, Révillon Y (1991) Transplantation hépatique et rénale dans le traitement de l'hyperoxalurie de type I. Arch Fr Pediatr 48:637–639
Ruder H, Otto G, Schutgens RBM, et al. (1991) Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1. Eur J Pediatr 150:56–58
De Pauw L, Gelin M, Danpure CJ, Vereerstraeten P, Adler M, Abramowicz D, Toussaint C (1990) Combined liver-kidney transplantation in primary hyperoxaluria type 1. Transplantation 50:866–887
Rodby RA, Tyszka TS, Williams JW (1991) Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation. Am J Med 90:468–504
Cuervas-Mons V (1986) An analysis of the early causes of death in 40 consecutive cases. Hepatology 6:495–501
McDiarmid SV, Ettenger RB, Fine RN, Busutill RW, Ament ME (1989) Serial decrease in glomerular filtration rate in long-term pediatric liver transplantation survivors treated with cyclosporine. Transplantation 47:314–318
Andrews WA, Arant BS, Byock B, Gray S, Schlatter MG, Coulin C (1991) The effect of cyclosporine A on long-term renal function in pediatric liver recipients. Transplant Proc 23:1452–1453
McDonald JC, Landreneau MD, Rohr MS, De Vault GA Jr (1989) Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect. N Engl J Med 321:1100–1103
Porayko MK, Wiesner RH, Hay JE, Krom RAF, Dickson ER, Beaver S, Schwerman L (1991) Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 23:1462–1465
Cochat P, Faure JL, Divry P, Danpure CJ, Descos B, Wright C, Takvorian P, Floret D (1989) Liver transplantation in primary hyperoxaluria type 1. Lancet I:1142–1143
Schürmann G, Schärer K, Wingen AM, Otto G, Herfarth C (1990) Early liver transplantation for primary hyperoxaluria type 1 in an infant with chronic renal failure. Nephrol Dial Transplant 5:825–827
Watts RWE (1990) Treatment of renal failure in the primary hyperoxalurias. Nephron 56:1–5
Scheinman JI (1991) Primary hyperoxaluria: therapeutic strategies for the 90's. Kidney Int 40:389–399
Ellis D, Avner ED, Starzl TE (1986) Renal failure in children with hepatic failure undergoing liver transplantation. J pediatr 108:393–398
Bonsel GJ, Essink-Bot ML, Klompmaker IJ, Sloof MJH (1992) Assessment of the quality of life before and following liver transplantation. Transplantation 53:796–800
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cochat, P., Schärer, K. Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?. Pediatr Nephrol 7, 212–218 (1993). https://doi.org/10.1007/BF00864408
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00864408